PAHC Long Put Strategy
PAHC (Phibro Animal Health Corporation), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries.
PAHC (Phibro Animal Health Corporation) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $1.43B, a trailing P/E of 15.01, a beta of 0.61 versus the broader market, a 52-week range of 22.51-60.08, average daily share volume of 326K, a public-listing history dating back to 2014, approximately 2K full-time employees. These structural characteristics shape how PAHC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.61 indicates PAHC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. PAHC pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long put on PAHC?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current PAHC snapshot
As of May 15, 2026, spot at $34.28, ATM IV 66.40%, IV rank 9.36%, expected move 19.04%. The long put on PAHC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on PAHC specifically: PAHC IV at 66.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a PAHC long put, with a market-implied 1-standard-deviation move of approximately 19.04% (roughly $6.53 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PAHC expiries trade a higher absolute premium for lower per-day decay. Position sizing on PAHC should anchor to the underlying notional of $34.28 per share and to the trader's directional view on PAHC stock.
PAHC long put setup
The PAHC long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PAHC near $34.28, the first option leg uses a $34.28 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PAHC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PAHC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $34.28 | N/A |
PAHC long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
PAHC long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on PAHC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on PAHC
Long puts on PAHC hedge an existing long PAHC stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying PAHC exposure being hedged.
PAHC thesis for this long put
The market-implied 1-standard-deviation range for PAHC extends from approximately $27.75 on the downside to $40.81 on the upside. A PAHC long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long PAHC position with one put per 100 shares held. Current PAHC IV rank near 9.36% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PAHC at 66.40%. As a Healthcare name, PAHC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PAHC-specific events.
PAHC long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PAHC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PAHC alongside the broader basket even when PAHC-specific fundamentals are unchanged. Long-premium structures like a long put on PAHC are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current PAHC chain quotes before placing a trade.
Frequently asked questions
- What is a long put on PAHC?
- A long put on PAHC is the long put strategy applied to PAHC (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With PAHC stock trading near $34.28, the strikes shown on this page are snapped to the nearest listed PAHC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PAHC long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the PAHC long put priced from the end-of-day chain at a 30-day expiry (ATM IV 66.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PAHC long put?
- The breakeven for the PAHC long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PAHC market-implied 1-standard-deviation expected move is approximately 19.04%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on PAHC?
- Long puts on PAHC hedge an existing long PAHC stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying PAHC exposure being hedged.
- How does current PAHC implied volatility affect this long put?
- PAHC ATM IV is at 66.40% with IV rank near 9.36%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.